54 results
424B5
NRIX
Nurix Therapeutics Inc
12 Apr 24
Prospectus supplement for primary offering
5:10pm
Act of 1995 concerning our business strategy and plans, future operating results and financial position, as well as our objectives and expectations … drug candidates;
our sales, marketing and distribution capabilities and strategy;
our ability to establish and maintain arrangements
424B5
NRIX
Nurix Therapeutics Inc
11 Apr 24
Prospectus supplement for primary offering
4:06pm
business strategy and plans, future operating results and financial position, as well as our objectives and expectations for our future operations. Any … , marketing and distribution capabilities and strategy;
our ability to establish and maintain arrangements for the manufacturing of our drug candidates
8-K
EX-99.1
gbuw7pgzk1 qtb0aol
8 Jan 24
Regulation FD Disclosure
7:03am
8-K
EX-99.1
mczgfbdfa8q35
11 Dec 23
Other Events
12:03pm
8-K
EX-99.1
o24fley
12 Oct 23
Nurix Therapeutics Reports Third Quarter Fiscal 2023 Financial Results and Provides a Corporate Update
4:03pm
8-K
EX-99.1
xizuojmu8d clk6bvkl
13 Jul 23
Nurix Therapeutics Reports Second Quarter Fiscal 2023 Financial Results and Provides a Corporate Update
4:18pm
8-K
EX-99.1
o0wfl
13 Apr 23
Nurix Therapeutics Reports First Quarter Fiscal 2023 Financial Results and Provides a Corporate Update
4:02pm
8-K
EX-99.2
rsd53qh4
12 Dec 22
Other Events
5:36pm
8-K
EX-99.1
31xgn5xi zgtupii
6 Oct 22
Nurix Therapeutics Reports Third Quarter Fiscal 2022 Financial Results and Provides a Corporate Update
4:10pm
8-K
EX-99.1
drg2moe3rs7gepow
14 Sep 22
Nurix Therapeutics Appoints Leading Industry Strategist Edward C. Saltzman to its Board of Directors
4:01pm
424B5
00acb2wgzq0dqs
8 Jul 22
Prospectus supplement for primary offering
4:10pm
424B5
n7dzzul9 t6qy97vy
8 Jul 22
Prospectus supplement for primary offering
4:09pm